Enhancing Drug Abuse Potential Assessments: The Role of Cognitive Test Batteries and Neuroimaging Techniques in Human Clinical Trials Drug abuse liability studies are vital for...
The Science Behind is playing a crucial role in the neurophysiological screening and monitoring of a phase I clinical trial for a new drug, MDI-26478,...
We’re excited to announce that we will be exhibiting at the 6th MarketsandMarkets Neuroscience R&D Conference – 9th – 10th October 2023 The 6th Annual...
Rare Disease Day is an important annual observance that raises awareness about rare diseases and their impact on patients’ lives. First established in 2008 by...
Recognised as the Best in Early Phase Neuroscience Clinical Trials: Our Company Wins European Enterprise Award. Exciting news! Our company has been awarded the...
Pharmaceutical companies are constantly searching for new and innovative ways to test the safety and efficacy of their drugs, and one promising method, TMS-EEG, is the...
Visit us at Biomarkers UK 2022 The Science Behind is pleased to announce that we will be attending Biomarkers UK 2022 in-person conference this Spring....
The Science Behind and contract research organisation Simbec-Orion are jointly hosting a free webinar on Wednesday 19th January on Embedding Neuroscience Techniques to Measure Target...
We are delighted to announce that The Science Behind has achieved certification for ISO9001:2015 for Quality Management Systems and ISO27001:2017 for Information Security Management Systems....
